Search Within

Kayleigh Diane Rutherford

Formats
  1. Meeting Abstract (4)
  2. Journal Article (2)
Groups
  1. Center for Hematologic Malignancies (6)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (6)
  3. Executive Committee, Center for Hematologic Malignancies (6)
  4. GSK Faculty (6)
  5. Computational Oncology Service (5)
  6. Epidemiology and Biostatistics (5)

More Groups

People
  1. Elli Papaemmanuil (5)
  2. Noushin Rahnamay Farnoud (3)
  3. Juan Arango Ossa (2)
  4. Ross Levine (2)
  5. Ahmet Zehir (1)
  6. Andrew Kung (1)

More People

Years
  1. 2023 (1)
  2. 2022 (5)
Publications
  1. Blood (4)
  2. Clinical Cancer Research (1)
  3. Swiss Medical Weekly (1)
Publishers
  1. American Society of Hematology (4)
  2. American Association for Cancer Research (1)
  3. E M H Swiss Medical Publishers Ltd (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Contribution of mutant HSC clones to immature and mature cells in MDS and CMML, and variations with AZA therapy
    Journal Article

    Schnegg-Kaufmann, A. S.; Thoms, J. A. I.; Bhuyan, G. S.; Hampton, H. R.; Vaughan, L.; Rutherford, K.; Kakadia, P. M.; Lee, H. M.; Johansson, E. M. V.; Failes, T. W.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Single cell genotyping of matched stem/progenitor and mature blood cells in treatment naive and AZA-treated MDS and CMML reveals significant contribution of mutated clones to blood production
    Meeting Abstract

    Schnegg-Kaufmann, A.; Thoms, J. A.; Bhuyan, G. S.; Hampton, H. R.; Vaughan, L.; Rutherford, K.; Kakadia, P. M.; Lee, H. M.; Johansson, E. M.; Failes, T.; more...
    Swiss Medical Weekly (2022)

    Fulltext@MSK | Save
  • Clinical response to azacytidine (AZA) is associated with increased contribution from mutated blood progenitors: Insights from single cell genotyping of matched stem/progenitor and mature blood cells from MDS/CMML patients pre- and post-AZA treatment
    Meeting Abstract

    Thoms, J. A. I.; Schnegg-Kaufmann, A.; Bhuyan, G. S.; Hampton, H. R.; Vaughan, L.; Rutherford, K.; Kakadia, P. M.; Lee, H. M.; Johansson, E.; Failes, T. W.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Mutational profile of children with myeloproliferative neoplasms
    Meeting Abstract

    Rutherford, K.; Farnoud, N.; Krishnan, A.; Rampal, R. K.; Levine, R. L.; Kucine, N.
    Blood (2022)

    Fulltext@MSK | Save
  • Long-term outcome of patients with follicular lymphoma is not fundamentally affected by KMT2D, EZH2, and CREBBP mutational status
    Meeting Abstract

    Bantilan, K. S.; Rutherford, K.; McCarter, J.; Farnoud, N.; Arango-Ossa, J. E.; Papaemmanuil, E.; Zelenetz, A. D.
    Blood (2022)

    Fulltext@MSK | Save
  • Bone marrow surveillance of pediatric cancer survivors identifies clones that predict therapy-related leukemia
    Journal Article

    Spitzer, B.; Rutherford, K. D.; Gundem, G.; McGovern, E. M.; Millard, N. E.; Arango Ossa, J. E.; Cheung, I. Y.; Gao, T.; Levine, M. F.; Zhang, Y.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save